Your browser doesn't support javascript.
loading
Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.
Tohge, Rie; Kaneko, Satoshi; Morise, Satoshi; Oki, Mitsuaki; Takenouchi, Norihiro; Murakami, Aya; Nakamura, Masataka; Kusaka, Hirofumi; Yakushiji, Yusuke.
Afiliación
  • Tohge R; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Kaneko S; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan. Electronic address: kanekosa@takii.kmu.ac.jp.
  • Morise S; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Oki M; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Takenouchi N; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Murakami A; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Nakamura M; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Kusaka H; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
  • Yakushiji Y; Department of Neurology, Kansai Medical University, Hirakata city, Osaka, Japan.
Neuropharmacology ; 198: 108771, 2021 10 15.
Article en En | MEDLINE | ID: mdl-34474045

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Secundaria / Levodopa / Neostriado / Antidiscinéticos / Discinesia Inducida por Medicamentos / Neuronas Serotoninérgicas / Zonisamida / Antiparkinsonianos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuropharmacology Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Secundaria / Levodopa / Neostriado / Antidiscinéticos / Discinesia Inducida por Medicamentos / Neuronas Serotoninérgicas / Zonisamida / Antiparkinsonianos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuropharmacology Año: 2021 Tipo del documento: Article País de afiliación: Japón